Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers

2021/08/03 by Antti Palomäki, Aarno Palotie, Jukka Koskela +6 · 16 citations
Medicine · #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Antifungal resistance and susceptibility #Pneumocystis jirovecii pneumonia detection and treatment

paper · pdf · doi:10.1136/annrheumdis-2021-220698

Abstract

OBJECTIVES: promoter variant. METHODS: promoter variant. RESULTS: non-carriers. The difference between risks started to emerge at age 65, with a higher risk among men. CONCLUSION: mutation carrier status, demonstrating the potential of genomics for risk stratification of RA-ILD.

Cited by

• Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset. [europepmc]
• Sexual Dimorphism in Interstitial Lung Disease. [europepmc]
• ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly. [europepmc]
• Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers. [europepmc]
• Rheumatoid arthritis-associated interstitial lung disease hotspots and future directions: A Web-of-Science based scientometric and visualization study. [europepmc]
• Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease. [europepmc]
• An immunogenetic basis for lung cancer risk. [europepmc]
• Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study. [europepmc]
• Genetic evidence reveals a causal relationship between rheumatoid arthritis and interstitial lung disease. [europepmc]
• Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences. [europepmc]
• Exploring Antifibrotic Strategies for Interstitial Lung Disease in Rheumatoid Arthritis: A Narrative Review. [europepmc]
• Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis. [europepmc]
• Advances in the Diagnosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Integrating Conventional Tools and Emerging Biomarkers. [europepmc]
• Pathogenesis and immune regulation of rheumatoid arthritis-associated interstitial lung disease: from basic research to clinical implications. [europepmc]
• The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic review. [europepmc]
• The Lung in Rheumatoid Arthritis—Friend or Enemy? [europepmc]

Related

• Fine-scale regional frequency of the MUC5B promoter variant correlates with healthcare burden of idiopathic pulmonary fibrosis
• Screening for Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Evidence and Next Steps Needed for Routine Clinical Use
• Assessing the promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease
• Age-based risk estimates for C9orf72RE-related diseases: Theoretical developments and added value for genetic counseling
• Enhancing Genetic Studies on Rheumatic Diseases in Latin America: The IARGE-RD Initiative